Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan

被引:38
作者
Masuda, H
Suzuki, H
Oshitani, H
Saito, R
Kawasaki, S
Nishikawa, M
Satoh, H
机构
[1] Niigata Univ, Sch Med, Dept Publ Hlth, Niigata 9518510, Japan
[2] Niigata Univ, Sch Med, Dept Med 2, Niigata 9518510, Japan
[3] Niigata Prefecture Res Lab Hlth & Environm Protec, Niigata 9502144, Japan
[4] Niigata Univ, Hosp Med, Div Pharm, Niigata 9518520, Japan
关键词
influenza A virus; amantadine-resistant; M2; protein; nursing home;
D O I
10.1111/j.1348-0421.2000.tb02571.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We surveyed the incidence of amantadine-resistant influenza A viruses both at sentinel surveillance sites and at nursing homes, and verified their types of change by partial nucleotide sequence analysis of the M2 protein. Fifty-five influenza A viruses from 27 sentinel surveillance sites during six influenza seasons from 1993 to 1999, and 26 influenza A viruses from 5 nursing homes from 1996 to 1999 were examined for susceptibility to the drug by virus titration in the presence or absence of amantadine, While amantadine-resistant viruses were not found in sentinel surveillance sites, a high frequency of resistance (8/26, 30.8%) in nursing homes was observed. Resistant viruses can occur quickly and be transmitted when used in an outbreak situation at nursing homes, where amantadine is used either for neurologic indications or for influenza treatment. Eight resistant viruses had a single amino acid change of the M2 protein at residue 30 or 31, In vitro, all 11 sensitive viruses turned resistant after 3 or 5 passages in the presence of 2 mu g/ml amantadine, and they showed an amino acid change at residue 27, 30, or 31, The predominant amino acid substitution in the M2 protein of resistant viruses is Ser-31-Asp (a change at 31, serine to asparagine), The results indicate that a monitoring system for amantadine-resistant influenza viruses should be established without delay in Japan.
引用
收藏
页码:833 / 839
页数:7
相关论文
共 24 条
[1]   RESISTANCE OF INFLUENZA-A VIRUS TO AMANTADINE AND RIMANTADINE - RESULTS OF ONE DECADE OF SURVEILLANCE [J].
BELSHE, RB ;
BURK, B ;
NEWMAN, F ;
CERRUTI, RL ;
SIM, IS .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (03) :430-435
[2]   GENETIC-BASIS OF RESISTANCE TO RIMANTADINE EMERGING DURING TREATMENT OF INFLUENZA-VIRUS INFECTION [J].
BELSHE, RB ;
SMITH, MH ;
HALL, CB ;
BETTS, R ;
HAY, AJ .
JOURNAL OF VIROLOGY, 1988, 62 (05) :1508-1512
[3]   PRODUCTION OF THE M2-PROTEIN OF INFLUENZA-A VIRUS IN INSECT CELLS IS ENHANCED IN THE PRESENCE OF AMANTADINE [J].
BLACK, RA ;
ROTA, PA ;
GORODKOVA, N ;
CRAMER, A ;
KLENK, HD ;
KENDAL, AP .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :1673-1677
[4]   Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial [J].
Carman, WF ;
Elder, AG ;
Wallace, LA ;
McAulay, K ;
Walker, A ;
Murray, GD ;
Stott, DJ .
LANCET, 2000, 355 (9198) :93-97
[5]  
*CDCP, 2000, MMWR-MORBID MORTAL W, V49, P16
[6]   AMANTADINE-RESISTANT INFLUENZA-A IN A NURSING FACILITY [J].
DEGELAU, J ;
SOMANI, SK ;
COOPER, SL ;
GUAY, DRP ;
CROSSLEY, KB .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (02) :390-392
[7]  
HALL CB, 1987, PEDIATRICS, V80, P275
[8]  
Hay A.J., 1992, SEMIN VIROL, V3, P21, DOI DOI 10.1016/J.BMC.2015.06.030
[9]   RECOVERY OF DRUG-RESISTANT INFLUENZA-A VIRUS DURING THERAPEUTIC USE OF RIMANTADINE [J].
HAYDEN, FG ;
SPERBER, SJ ;
BELSHE, RB ;
CLOVER, RD ;
HAY, AJ ;
PYKE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1741-1747
[10]   EMERGENCE AND APPARENT TRANSMISSION OF RIMANTADINE-RESISTANT INFLUENZA-A VIRUS IN FAMILIES [J].
HAYDEN, FG ;
BELSHE, RB ;
CLOVER, RD ;
HAY, AJ ;
OAKES, MG ;
SOO, WJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (25) :1696-1702